Icad Competitors

ICAD Stock  USD 1.28  0.03  2.40%   
Icad Inc competes with AmerisourceBergen, Abbott Laboratories, Adicet Bio, Acadia Healthcare, and Addus HomeCare; as well as few others. The company conducts business under Health Care Technology sector and is part of Health Care industry. Analyzing Icad competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Icad to its intrinsic valuation because they are able to contrast its competitors on a relative basis.
You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of Icad competition on your existing holdings. Check out Icad Correlation with its peers.For information on how to trade Icad Stock refer to our How to Trade Icad Stock guide.
As of March 26, 2023, Return on Investment is expected to decline to -31.7. In addition to that, Return on Average Assets is expected to decline to -0.16. Icad Goodwill and Intangible Assets are projected to decrease significantly based on the last few years of reporting. The past year's Goodwill and Intangible Assets were at 8.14 Million. The current year Revenue to Assets is expected to grow to 0.54, whereas Current Assets are forecasted to decline to about 47.8 M.
Specify up to 10 symbols:
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Icad's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Icad in the context of predictive analytics.
LowEstimated ValueHigh
LowReal ValueHigh
LowNext ValueHigh
4 Analysts
LowTarget PriceHigh
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Icad. Your research has to be compared to or analyzed against Icad's peers to derive any actionable benefits. When done correctly, Icad's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Icad Inc.

Icad Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Icad and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of Icad and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Icad Inc does not affect the price movement of the other competitor.

Related Correlations

Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Risk-Adjusted Indicators

Nowadays, there is a big difference between Icad Stock performing well and Icad company doing well compared to the competition. There are way too many exceptions to the normal that investors can tell for sure what's good or bad unless they analyze Icad's multiple risk-adjusted performance indicators. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
At Risk
ABC 0.91 (0.09)  0.00 (0.21)  0.00 (0.06)  0.00  1.63 (1.64)  6.89 
ABT 0.97 (0.10)  0.00 (0.14)  0.00 (0.08)  0.00  1.79 (2.04)  5.20 
ACET 3.21 (0.42)  0.00 (0.31)  0.00 (0.1)  0.00  6.68 (8.18)  24.84 
ACHC 1.20 (0.22)  0.00 (0.23)  0.00 (0.12)  0.00  2.41 (2.78)  12.64 
ADUS 1.26  0.02  0.01  0.00  1.62  0.014 (1.27)  2.46 (2.43)  6.60 
AEMD 5.35  0.93  0.17  0.36  4.47  0.11 (8.24)  13.79 (7.94)  45.48 
AHCO 2.28 (0.38)  0.00 (0.32)  0.00 (0.09)  0.00  3.63 (5.38)  31.86 
AIH 4.16  0.30  0.04  0.16  5.82  0.05 (4.85)  8.59 (7.19)  31.70 
ALGN 2.34  0.77  0.31  0.43  1.92  0.18 (2.75)  5.24 (4.02)  32.06 

Cross Equities Net Income Analysis

Select Fundamental

ABC719 M719 M433.7 M274.2 M(138.2 M)1.4 B364.5 M1.7 B855.4 M(3.4 B)1.5 B1.7 BB2.1 B
ABTBBB2.6 B2.3 B4.4 B1.4 B477 M2.4 B3.7 B4.5 B7.1 B6.9 B5.8 B
ACET(33.8 M)(33.8 M)(33.8 M)(33.8 M)(33.8 M)(33.8 M)(33.8 M)(33.8 M)(9.3 M)(28.1 M)(36.7 M)(62 M)(69.8 M)(71.6 M)
ACHC20.4 M20.4 M20.4 M42.6 M83 M112.6 M6.1 M199.8 M(175.8 M)108.9 M(672.1 M)190.6 M273.1 M294.7 M
ADUS7.6 M7.6 M7.6 M19.1 M12.2 M11.6 M12.2 M12 M16.4 M25.2 M33.1 M45.1 M46 M36.9 M
AEMD(8.1 M)(8.1 M)(4.9 M)(13.4 M)(6.8 M)(4.9 M)(7.3 M)(5.7 M)(6.2 M)(6.4 M)(7.9 M)(10.4 M)(9.4 M)(10.1 M)
AHCO(4.2 M)(4.2 M)(4.2 M)(4.2 M)(4.2 M)(4.2 M)(4.2 M)9.7 M23.3 M(21.3 M)(161.6 M)156.2 M69.3 M74.8 M
AIH50.4 M50.4 M50.4 M50.4 M50.4 M50.4 M50.4 M(76.7 M)(255.2 M)136.3 M(235.5 M)(586.6 M)(528 M)(541.9 M)
ALGN58.7 M58.7 M58.7 M64.3 M145.8 M144 M189.7 M231.4 M400.2 M442.8 M1.8 B772 M361.6 M431.7 M

Icad Inc and related stocks such as AmerisourceBergen, Abbott Laboratories, Adicet Bio, Acadia Healthcare, Addus HomeCare, Aethlon Medical, Adapthealth Corp, Aesthetic Medical Intl, and Align Technology Net Income description

Net income is one of the most important fundamental items in finance. It plays a large role in Icad Inc financial statement analysis. It represents the amount of money remaining after all of Icad Inc operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. The portion of profit or loss for the period; net of income taxes; which is attributable to the parent after the deduction of Net Income Available to Non-controlling Interests from Consolidated Income; and before the deduction of Preferred Dividends.

Icad Competitive Analysis

The better you understand Icad competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Icad's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Icad's competition over several years is one of the best ways to analyze its investment potential.
 Better Than Average     
 Worse Than Peers    View Performance Chart
Market Volatility
(90 Days Market Risk)
Market Performance
(90 Days Performance)
Odds of Financial Distress
(Probability Of Bankruptcy)
Current Valuation
(Equity Enterprise Value)
Buy or Sell Advice
(Average Analysts Consensus)
Trade Advice
(90 Days Macroaxis Advice)
Number of Shares Shorted
Shares Owned by Insiders
Current Ratio
Net Asset
Profit Margin
Operating Margin
Current Valuation
Cash Flow from Operations
Retained Earnings
Current Asset
Five Year Return
Price to Book
Shares Outstanding
Annual Yield
Total Debt
Return On Equity
Price to Earning
Z Score
Shares Owned by Institutions
Return On Asset
Book Value Per Share
Cash and Equivalents
Price to Earnings To Growth
Current Liabilities
Total Asset
Short Ratio
Target Price
Last Dividend Paid
Price to Sales
Market Capitalization
Cash per Share
Net Income
Earnings Per Share
Debt to Equity
Working Capital
Gross Profit
Coefficient Of Variation
Mean Deviation
Jensen Alpha
Total Risk Alpha
Sortino Ratio
Downside Variance
Standard Deviation
Potential Upside
Treynor Ratio
Maximum Drawdown
Market Risk Adjusted Performance
Risk Adjusted Performance
Semi Deviation
Information Ratio
Value At Risk
Expected Short fall
Downside Deviation
Semi Variance

Icad Competition Performance Charts

Five steps to successful analysis of Icad Competition

Icad's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Icad Inc in relation to its competition. Icad's competition analysis typically involves several steps, including::
  • Identifying the key players in the market: This involves identifying the major competitors of Icad in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Icad's competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Icad Inc, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Icad position

In addition to having Icad in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Apparel Thematic Idea Now

Apparel Theme
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Apparel theme has 41 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Apparel Theme or any other thematic opportunities.
View All  Next Launch
Check out Icad Correlation with its peers.For information on how to trade Icad Stock refer to our How to Trade Icad Stock guide. Note that the Icad Inc information on this page should be used as a complementary analysis to other Icad's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.

Complementary Tools for Icad Stock analysis

When running Icad Inc price analysis, check to measure Icad's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Icad is operating at the current time. Most of Icad's value examination focuses on studying past and present price action to predict the probability of Icad's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Icad's price. Additionally, you may evaluate how the addition of Icad to your portfolios can decrease your overall portfolio volatility.
Fund Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Piotroski F Score
Get Piotroski F Score based on binary analysis strategy of nine different fundamentals
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Is Icad's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Icad. If investors know Icad will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Icad listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
Revenue Per Share
Quarterly Revenue Growth
Return On Assets
Return On Equity
The market value of Icad Inc is measured differently than its book value, which is the value of Icad that is recorded on the company's balance sheet. Investors also form their own opinion of Icad's value that differs from its market value or its book value, called intrinsic value, which is Icad's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Icad's market value can be influenced by many factors that don't directly affect Icad's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Icad's value and its price as these two are different measures arrived at by different means. Investors typically determine Icad value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Icad's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.